Literature DB >> 21801200

Reversal of acute systolic dysfunction and cardiogenic shock in hypertrophic cardiomyopathy by surgical relief of obstruction.

Mark V Sherrid1, Sandhya K Balaran, Eva Korzeniecki, Farooq A Chaudhry, Daniel G Swistel.   

Abstract

A 70-year-old male with known hypertrophic cardiomyopathy (HCM) and latent obstruction presented with new onset of cardiogenic shock. He had a new resting left ventricular (LV) outflow gradient of 90 mmHg, and new severe LV systolic dysfunction. Because of rapid deterioration despite medical management he was urgently sent for surgical relief of obstruction, which immediately reversed both the LV dysfunction and shock. A second patient, a 58-year-old male also with hypertrophic cardiomyopathy and latent obstruction presented with collapse, cardiogenic shock, 135 mmHg resting LV outflow gradient and new severe LV systolic dysfunction. His profound shock was irreversible with pharmacologic management, but surgical relief of obstruction reversed both his LV dysfunction and shock. Echocardiography plays a pivotal role in the management of these acutely ill patients.
© 2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21801200     DOI: 10.1111/j.1540-8175.2011.01459.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  4 in total

Review 1.  Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Julian O M Ormerod; Michael P Frenneaux; Mark V Sherrid
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

2.  Conventional cardiopulmonary resuscitation-induced refractory cardiac arrest due to latent left ventricular outflow tract obstruction due to a sigmoid septum: a case report.

Authors:  Toshinobu Yamagishi; Takahiro Tanabe; Hiroshi Fujita; Kazuki Miyazaki; Takahiro Yukawa; Kazuhiro Sugiyama; Yuichi Hamabe
Journal:  J Med Case Rep       Date:  2018-08-20

3.  Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy.

Authors:  Mark V Sherrid; Daniel G Swistel; Iacopo Olivotto; Maurizio Pieroni; Omar Wever-Pinzon; Katherine Riedy; Richard G Bach; Mustafa Husaini; Sharon Cresci; Alex Reyentovich; Daniele Massera; Martin S Maron; Barry J Maron; Bette Kim
Journal:  J Am Heart Assoc       Date:  2021-10-12       Impact factor: 5.501

Review 4.  Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice.

Authors:  Mark V Sherrid
Journal:  Curr Cardiol Rev       Date:  2016
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.